Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Pilot Study to Evaluate the Combination of VB10.NEO with NKTR-214 in Patients with Advanced or Metastatic Squamous Cell Carcinoma of Head and Neck

Trial Profile

A Pilot Study to Evaluate the Combination of VB10.NEO with NKTR-214 in Patients with Advanced or Metastatic Squamous Cell Carcinoma of Head and Neck

Status: Planning
Phase of Trial: Phase I

Latest Information Update: 26 Jun 2019

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Bempegaldesleukin (Primary) ; VB10-NEO (Primary)
  • Indications Head and neck cancer; Squamous cell cancer
  • Focus Adverse reactions
  • Most Recent Events

    • 02 Apr 2019 According to a Nektar Therapeutics media release, this study is planned to begin mid-2019.
    • 26 Sep 2018 According to a Vaccibody media release, under the terms of the agreement and following the completion of this pilot study, the two companies will evaluate next steps for development of the combination regimen.
    • 26 Sep 2018 According to a Vaccibody media release, the company announced a new clinical collaboration with Nektar Therapeutics to evaluate Vaccibodys VB10.NEO in combination with Nektars NKTR-214.Nektar and Vaccibody each will maintain ownership of their own compounds in the clinical collaboration, and the two companies will jointly own clinical data that relate to the combination of VB10.NEO and NKTR-214.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top